Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Padagis LLC clinical trials
Part of Altaris, LLC.
The registry lists 37 studies whose lead sponsor is Padagis LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 26, 2026.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Padagis LLC.
- Padagis LLC37 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 37 of 37.
- Bioequivalence Study of Two Treatments for the Treatment of Plaque PsoriasisCompletedNCT05763082Phase 3
- To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesCompletedNCT04944290Phase 3
- Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel FormulationsCompletedNCT01044264Not applicable
- A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% FormulationsCompletedNCT01039584Not applicable
- A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting ConditionsCompletedNCT00992238Phase 1
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both EyesCompletedNCT04024072Phase 3
- To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin LesionsCompletedNCT04155203Phase 3
- Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol FoamCompletedNCT02800824Phase 1
- Safety Study of Entocort for Children With Crohn's DiseaseCompletedNCT01444092Phase 3
- Safety and Maintenance Study of Entocort for Children With Crohn's DiseaseCompletedNCT01453946Phase 3
- Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the FaceCompletedNCT03393494Phase 3
- Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the FaceCompletedNCT02800148Phase 3
- An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With RosaceaCompletedNCT03352323Phase 3
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne VulgarisCompletedNCT02515305Phase 3
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal AtrophyCompletedNCT02770365Phase 3
- Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of RosaceaCompletedNCT02795117Phase 3
- To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic KeratosisCompletedNCT02385318Phase 3
- To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic KeratosisCompletedNCT02459795Phase 3
- Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne VulgarisCompletedNCT02525549Phase 3
- Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea PedisCompletedNCT00804193Not applicable
- A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne VulgarisCompletedNCT01796665Phase 3
- Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of RosaceaCompletedNCT02385240Phase 3
- Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic RhinitisCompletedNCT02230696Phase 3
- Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex LabialisCompletedNCT02265913Phase 3
- A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)CompletedNCT01673659Phase 3
- Bioavailability of Prochlorperazine Suppositories, 25 mgCompletedNCT00992472Phase 1
- Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical CreamsCompletedNCT00803465
- Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical CreamsCompletedNCT00803166
- Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical CreamsCompletedNCT00800293
- Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical OintmentsCompletedNCT00802958
- Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical FoamsCompletedNCT00803439
- Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical OintmentsCompletedNCT00803218
- Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical LotionsCompletedNCT00805155
- Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema FormulationsCompletedNCT00802451Not applicable
- Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical GelsCompletedNCT01138514Phase 3
- Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea PedisCompletedNCT00802672Phase 3
- Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal CandidiasisCompletedNCT00803738Not applicable